Author:
Aguiar Bujanda D.,Bohn Sarmiento U.,Cabrera Suárez M.Á.,Aguiar Morales J.
Reference23 articles.
1. Metastatic bone disease: clinical features, pathophysiology and treatment strategies;Coleman;Cancer Treat Rev,2001
2. Management of the adverse effects associated with intravenous bisphosphonates;Tanvetyanon;Ann Oncol,2006
3. Safety of intravenous and oral bisphosphonates and compliance with dosing regimens;Conte;Oncologist,2004
4. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial;Rosen;Cancer J,2001
5. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial;Rosen;Cancer,2003
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献